Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Location SAINT LOUIS, MO 63110 Scheduled Hours 40 Position Summary The Jimenez laboratory focuses on understanding immunotherapy effects on the heart. The lab uses mice and surgical modeling tools
-
Salary Range $43,805-70,075/year Type of Position Staff Position Time Status Full-Time Required Education MS Click here for more information about equivalencies: https://hr.uky.edu/employment/working-uk
-
, focusing on mechanisms of human T cell differentiation and cellular immunotherapy. The ideal applicant will have strong quantitative skills and the ability to work independently (in a see-one, do-one, teach
-
challenges, and providing allergen immunotherapy. These services will be performed at the main campus of Children’s Hospital Colorado and at a Network of Care location. The candidate will participate in 6-12
-
approaches to immunotherapies. The focus of the ICCVS is the development of personalized vaccine against non-small cell lung cancer (NSCLC). The approach is based on use of cancer specific T cells
-
complex cranial neurosurgery and neuro-oncology. Candidates with an additional Ph.D. degree in biology related fields and specific focus of interest in immunotherapy and brain tumors are preferred
-
grade culture of immunotherapies, continuous human cell lines, multi potent stem cells including mesenchymal stromal cells (MSC), hematopoietic stem cells (HSC) and pluripotent stem cells such as human
-
Basic Life Support (BLS), or UC Davis Health CPR Chemotherapy Biotherapy Certification- ONS/ONCC Chemotherapy Immunotherapy Certification (or within 6 months of hire) Graduation from an accredited school
-
, transplantation models, or advanced immunological techniques. Experience with vaccine development, immunotherapy, or translational immunology. Interest in translational research related to hematologic disorders
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 1 month ago
of self-tolerance to the insulin producing beta cells, and 2) Development of immunotherapies for T1D. The work makes use of several genetically manipulated mouse models of T1D, as well as humanized mouse